[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Uveitis Treatment Market By Drug Class (Anti-inflammatory, Immunotherapy & Targeted Therapies, Antimicrobial Drugs and Other Drug Class) By Disease Type (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis and Panuveitis) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online stores) By Region, Industry Analysis and Forecast, 2019 - 2025

March 2020 | 214 pages | ID: G823D751D294EN
KBV Research

US$ 3,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The Global Uveitis Treatment Market size is expected to reach $686.1 Million by 2025, rising at a market growth of 5.5% CAGR during the forecast period. Uveitis is the inflammation of the middle tissue layer in the uvea eyewall which consists of the iris, choroid, and ciliary body. Various drug formulations such as anti-inflammatory drugs, cycloplegic agents, antimicrobial drugs, immunotherapy & targeted therapies, and others are used for uveitis treatment. These involve anterior uveitis, intermediate uveitis, posterior uveitis, and panuveitis. Inflammation of the iris called iritis or anterior uveitis is the most prevalent form of uveitis.

Increased prevalence of uveitis and growing awareness among the patient population with increased acceptance of innovative treatments is expected to drive the growth of the market. In addition, convenient access to uveitis treatment, increased demand for uveitis medications, and a boom in R&D activities to improve ideal uveitis treatment to further drive the growth of the industry.

Nevertheless, it is anticipated that the uncertain etiology and pathophysiology of uveitis would hinder market development. In addition, untapped capacity offered by emerging economies is presenting lucrative opportunities for market growth over the forecast period. Nonetheless, there is likely to be a shortage of effective treatment for uveitis disorder to limit the market growth.

Uveitis is considered the leading cause of blindness in the United States, with a steady rise in prevalence. Corticosteroid is considered the first-line treatment for uveitis. A large number of compounds for treating uveitis are lined up in growth. Leading industry players are adding new drugs to improve their product portfolio. The procedure for the sterile formulations, however, is highly complex and businesses are likely to align themselves with the GMP and regulatory requirements for producing their products.

Based on Drug Class, the market is segmented into Anti-inflammatory, Immunotherapy & Targeted Therapies, Antimicrobial Drugs and Other Drug Class. Based on Disease Type, the market is segmented into Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis and Panuveitis. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online stores. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Alimera Sciences, Inc., Enzo Biochem, Inc., Amgen, Inc., Bausch Health Companies, Inc., Clearside Biomedical, Inc., EyePoint Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., TopiVert Ltd., and Novartis AG.

Strategies deployed in Uveitis Treatment Market
Mar-2020: Clearside Biomedical announced an agreement with Arctic Vision, a company focused on developing and commercializing innovative ophthalmology therapies in China and Asia. Under this agreement, the latter company has acquired an exclusive license for the commercialization and development of XIPERE (triamcinolone acetonide suprachoroidal injectable suspension) in Greater China (mainland China, Hong Kong, Macau and Taiwan) and South Korea.

Feb-2020: Santen Pharmaceutical signed an agreement with Verily, an Alphabet company. Following the agreement, the companies would establish a joint venture focused on applying microelectronics and scalable digital technologies to ophthalmology.

Oct-2019: Bausch Health Ireland signed an agreement with Clearside Biomedical. The agreement granted Bausch with an exclusive license for developing, manufacturing, distributing, promoting, marketing, and commercializing the suprachoroidal injection device.

Sep-2019: Alimera Sciences launched ILUVIEN in Germany. This solution has been used in prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye (NIPU).

Jul-2019: Novartis completed the acquisition of Xiidra (lifitegrast ophthalmic solution), the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation caused by the disease. The acquisition enabled the company to deliver medicine for patients suffering from a variety of eye diseases.

Mar-2019: Novartis got FDA approval for Mayzent (siponimod), a new solution for the treatment of relapsing forms of multiple sclerosis (RMS).

Feb-2019: EyePoint Pharmaceuticals released the Yutiq, a 3-year micro-insert for the treatment of chronic noninfectious uveitis, which affects the posterior segment of the eye. The company also announced the launch of EyePoint Assist, a program for ensuring access to Yutiq for eligible patients in need of financial assistance.

Oct-2018: Amgen introduced Amgevita in Europe. This therapy is available in the 28 countries of the European Union, plus Norway, Iceland, and Liechtenstein. Amgevita is a human antibody that has been designed for targeting the human tumor necrosis factor alpha (TNF?), an immune factor that regulates the inflammatory response.

Mar-2018: pSivida acquired Icon Bioscience and its FDA-approved dexamethasone intraocular suspension designed to treat postoperative inflammation. Following the acquisition, both the companies have combined their businesses and started doing business as EyePoint Pharmaceuticals.

Jul-2016: AbbVie got FDA approval for Humira, a new therapy for non-infectious intermediate, posterior, and panuveitis. This is a non-corticosteroid treatment option for certain types of uveitis, an eye disease that can flare and impact vision.

Scope of the Study

Market Segmentation:

By Drug Class
  • Anti-inflammatory
  • Immunotherapy & Targeted Therapies
  • Antimicrobial Drugs
  • Other Drug Class
By Disease Type
  • Anterior Uveitis
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online stores
By Geography
  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA
Companies Profiled
  • AbbVie, Inc.
  • Alimera Sciences, Inc.
      • Enzo Biochem, Inc.
  • Amgen, Inc.
  • Bausch Health Companies, Inc.
  • Clearside Biomedical, Inc.
  • EyePoint Pharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • TopiVert Ltd.
  • Novartis AG
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 Global Uveitis Treatment Market, by Drug Class
  1.4.2 Global Uveitis Treatment Market, by Disease Type
  1.4.3 Global Uveitis Treatment Market, by Distribution Channel
  1.4.4 Global Uveitis Treatment Market, by Geography
1.5 Methodology for the research

CHAPTER 2. MARKET OVERVIEW

2.1 Introduction
  2.1.1 Overview
  2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
  2.2.1 Market Drivers
  2.2.2 Market Restraints

CHAPTER 3. GLOBAL UVEITIS TREATMENT MARKET BY DRUG CLASS

3.1 Global Anti-inflammatory Market by Region
3.2 Global Immunotherapy & Targeted Therapies Market by Region
3.3 Global Antimicrobial Drugs Market by Region
3.4 Global Other Drug Class Market by Region

CHAPTER 4. GLOBAL UVEITIS TREATMENT MARKET BY DISEASE TYPE

4.1 Global Anterior Uveitis Market by Region
4.2 Global Posterior Uveitis Market by Region
4.3 Global Intermediate Uveitis Market by Region
4.4 Global Other Diseases Market by Region

CHAPTER 5. GLOBAL UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL

5.1 Global Hospital Pharmacies Market by Region
5.2 Global Retail Pharmacies Market by Region
5.3 Global Online stores Market by Region

CHAPTER 6. GLOBAL UVEITIS TREATMENT MARKET BY REGION

6.1 North America Uveitis Treatment Market
  6.1.1 North America Uveitis Treatment Market by Drug Class
    6.1.1.1 North America Anti-inflammatory Market by Country
    6.1.1.2 North America Immunotherapy & Targeted Therapies Market by Country
    6.1.1.3 North America Antimicrobial Drugs Market by Country
    6.1.1.4 North America Other Drug Class Market by Country
  6.1.2 North America Uveitis Treatment Market by Disease Type
    6.1.2.1 North America Anterior Uveitis Market by Country
    6.1.2.2 North America Posterior Uveitis Market by Country
    6.1.2.3 North America Intermediate Uveitis Market by Country
    6.1.2.4 North America Other Disease Types Market by Country
  6.1.3 North America Uveitis Treatment Market by Distribution Channel
    6.1.3.1 North America Hospital Pharmacies Market by Country
    6.1.3.2 North America Retail Pharmacies Market by Country
    6.1.3.3 North America Online stores Market by Country
  6.1.4 North America Uveitis Treatment Market by Country
    6.1.4.1 USA Uveitis Treatment Market
      6.1.4.1.1 USA Uveitis Treatment Market by Drug Class
      6.1.4.1.2 USA Uveitis Treatment Market by Disease Type
      6.1.4.1.3 USA Uveitis Treatment Market by Distribution Channel
    6.1.4.2 Canada Uveitis Treatment Market
      6.1.4.2.1 Canada Uveitis Treatment Market by Drug Class
      6.1.4.2.2 Canada Uveitis Treatment Market by Disease Type
      6.1.4.2.3 Canada Uveitis Treatment Market by Distribution Channel
    6.1.4.3 Mexico Uveitis Treatment Market
      6.1.4.3.1 Mexico Uveitis Treatment Market by Drug Class
      6.1.4.3.2 Mexico Uveitis Treatment Market by Disease Type
      6.1.4.3.3 Mexico Uveitis Treatment Market by Distribution Channel
    6.1.4.4 Rest of North America Uveitis Treatment Market
      6.1.4.4.1 Rest of North America Uveitis Treatment Market by Drug Class
      6.1.4.4.2 Rest of North America Uveitis Treatment Market by Disease Type
      6.1.4.4.3 Rest of North America Uveitis Treatment Market by Distribution Channel
6.2 Europe Uveitis Treatment Market
  6.2.1 Europe Uveitis Treatment Market by Drug Class
    6.2.1.1 Europe Anti-inflammatory Market by Country
    6.2.1.2 Europe Immunotherapy & Targeted Therapies Market by Country
    6.2.1.3 Europe Antimicrobial Drugs Market by Country
    6.2.1.4 Europe Other Drug Class Market by Country
  6.2.2 Europe Uveitis Treatment Market by Disease Type
    6.2.2.1 Europe Anterior Uveitis Market by Country
    6.2.2.2 Europe Posterior Uveitis Market by Country
    6.2.2.3 Europe Intermediate Uveitis Market by Country
    6.2.2.4 Europe Other Diseases Market by Country
  6.2.3 Europe Uveitis Treatment Market by Distribution Channel
    6.2.3.1 Europe Hospital Pharmacies Market by Country
    6.2.3.2 Europe Retail Pharmacies Market by Country
    6.2.3.3 Europe Online stores Market by Country
  6.2.4 Europe Uveitis Treatment Market by Country
    6.2.4.1 Germany Uveitis Treatment Market
      6.2.4.1.1 Germany Uveitis Treatment Market by Drug Class
      6.2.4.1.2 Germany Uveitis Treatment Market by Disease Type
      6.2.4.1.3 Germany Uveitis Treatment Market by Distribution Channel
    6.2.4.2 UK Uveitis Treatment Market
      6.2.4.2.1 UK Uveitis Treatment Market by Drug Class
      6.2.4.2.2 UK Uveitis Treatment Market by Disease Type
      6.2.4.2.3 UK Uveitis Treatment Market by Distribution Channel
    6.2.4.3 France Uveitis Treatment Market
      6.2.4.3.1 France Uveitis Treatment Market by Drug Class
      6.2.4.3.2 France Uveitis Treatment Market by Disease Type
      6.2.4.3.3 France Uveitis Treatment Market by Distribution Channel
    6.2.4.4 Russia Uveitis Treatment Market
      6.2.4.4.1 Russia Uveitis Treatment Market by Drug Class
      6.2.4.4.2 Russia Uveitis Treatment Market by Disease Type
      6.2.4.4.3 Russia Uveitis Treatment Market by Distribution Channel
    6.2.4.5 Spain Uveitis Treatment Market
      6.2.4.5.1 Spain Uveitis Treatment Market by Drug Class
      6.2.4.5.2 Spain Uveitis Treatment Market by Disease Type
      6.2.4.5.3 Spain Uveitis Treatment Market by Distribution Channel
    6.2.4.6 Italy Uveitis Treatment Market
      6.2.4.6.1 Italy Uveitis Treatment Market by Drug Class
      6.2.4.6.2 Italy Uveitis Treatment Market by Disease Type
      6.2.4.6.3 Italy Uveitis Treatment Market by Distribution Channel
    6.2.4.7 Rest of Europe Uveitis Treatment Market
      6.2.4.7.1 Rest of Europe Uveitis Treatment Market by Drug Class
      6.2.4.7.2 Rest of Europe Uveitis Treatment Market by Disease Type
      6.2.4.7.3 Rest of Europe Uveitis Treatment Market by Distribution Channel
6.3 Asia Pacific Uveitis Treatment Market
  6.3.1 Asia Pacific Uveitis Treatment Market by Drug Class
    6.3.1.1 Asia Pacific Anti-inflammatory Market by Country
    6.3.1.2 Asia Pacific Immunotherapy & Targeted Therapies Market by Country
    6.3.1.3 Asia Pacific Antimicrobial Drugs Market by Country
    6.3.1.4 Asia Pacific Other Drug Class Market by Country
  6.3.2 Asia Pacific Uveitis Treatment Market by Disease Type
    6.3.2.1 Asia Pacific Anterior Uveitis Market by Country
    6.3.2.2 Asia Pacific Posterior Uveitis Market by Country
    6.3.2.3 Asia Pacific Intermediate Uveitis Market by Country
    6.3.2.4 Asia Pacific Other Diseases Market by Country
  6.3.3 Asia Pacific Uveitis Treatment Market by Distribution Channel
    6.3.3.1 Asia Pacific Hospital Pharmacies Market by Country
    6.3.3.2 Asia Pacific Retail Pharmacies Market by Country
    6.3.3.3 Asia Pacific Online stores Market by Country
  6.3.4 Asia Pacific Uveitis Treatment Market by Country
    6.3.4.1 China Uveitis Treatment Market
      6.3.4.1.1 China Uveitis Treatment Market by Drug Class
      6.3.4.1.2 China Uveitis Treatment Market by Disease Type
      6.3.4.1.3 China Uveitis Treatment Market by Distribution Channel
    6.3.4.2 Japan Uveitis Treatment Market
      6.3.4.2.1 Japan Uveitis Treatment Market by Drug Class
      6.3.4.2.2 Japan Uveitis Treatment Market by Disease Type
      6.3.4.2.3 Japan Uveitis Treatment Market by Distribution Channel
    6.3.4.3 India Uveitis Treatment Market
      6.3.4.3.1 India Uveitis Treatment Market by Drug Class
      6.3.4.3.2 India Uveitis Treatment Market by Disease Type
      6.3.4.3.3 India Uveitis Treatment Market by Distribution Channel
    6.3.4.4 South Korea Uveitis Treatment Market
      6.3.4.4.1 South Korea Uveitis Treatment Market by Drug Class
      6.3.4.4.2 South Korea Uveitis Treatment Market by Disease Type
      6.3.4.4.3 South Korea Uveitis Treatment Market by Distribution Channel
    6.3.4.5 Singapore Uveitis Treatment Market
      6.3.4.5.1 Singapore Uveitis Treatment Market by Drug Class
      6.3.4.5.2 Singapore Uveitis Treatment Market by Disease Type
      6.3.4.5.3 Singapore Uveitis Treatment Market by Distribution Channel
    6.3.4.6 Malaysia Uveitis Treatment Market
      6.3.4.6.1 Malaysia Uveitis Treatment Market by Drug Class
      6.3.4.6.2 Malaysia Uveitis Treatment Market by Disease Type
      6.3.4.6.3 Malaysia Uveitis Treatment Market by Distribution Channel
    6.3.4.7 Rest of Asia Pacific Uveitis Treatment Market
      6.3.4.7.1 Rest of Asia Pacific Uveitis Treatment Market by Drug Class
      6.3.4.7.2 Rest of Asia Pacific Uveitis Treatment Market by Disease Type
      6.3.4.7.3 Rest of Asia Pacific Uveitis Treatment Market by Distribution Channel
6.4 LAMEA Uveitis Treatment Market
  6.4.1 LAMEA Uveitis Treatment Market by Drug Class
    6.4.1.1 LAMEA Anti-inflammatory Market by Country
    6.4.1.2 LAMEA Immunotherapy & Targeted Therapies Market by Country
    6.4.1.3 LAMEA Antimicrobial Drugs Market by Country
    6.4.1.4 LAMEA Other Drug Class Market by Country
  6.4.2 LAMEA Uveitis Treatment Market by Disease Type
    6.4.2.1 LAMEA Anterior Uveitis Market by Country
    6.4.2.2 LAMEA Posterior Uveitis Market by Country
    6.4.2.3 LAMEA Intermediate Uveitis Market by Country
    6.4.2.4 LAMEA Other Diseases Market by Country
  6.4.3 LAMEA Uveitis Treatment Market by Distribution Channel
    6.4.3.1 LAMEA Hospital Pharmacies Market by Country
    6.4.3.2 LAMEA Retail Pharmacies Market by Country
    6.4.3.3 LAMEA Online stores Market by Country
  6.4.4 LAMEA Uveitis Treatment Market by Country
    6.4.4.1 Brazil Uveitis Treatment Market
      6.4.4.1.1 Brazil Uveitis Treatment Market by Drug Class
      6.4.4.1.2 Brazil Uveitis Treatment Market by Disease Type
      6.4.4.1.3 Brazil Uveitis Treatment Market by Distribution Channel
    6.4.4.2 Argentina Uveitis Treatment Market
      6.4.4.2.1 Argentina Uveitis Treatment Market by Drug Class
      6.4.4.2.2 Argentina Uveitis Treatment Market by Disease Type
      6.4.4.2.3 Argentina Uveitis Treatment Market by Distribution Channel
    6.4.4.3 UAE Uveitis Treatment Market
      6.4.4.3.1 UAE Uveitis Treatment Market by Drug Class
      6.4.4.3.2 UAE Uveitis Treatment Market by Disease Type
      6.4.4.3.3 UAE Uveitis Treatment Market by Distribution Channel
    6.4.4.4 Saudi Arabia Uveitis Treatment Market
      6.4.4.4.1 Saudi Arabia Uveitis Treatment Market by Drug Class
      6.4.4.4.2 Saudi Arabia Uveitis Treatment Market by Disease Type
      6.4.4.4.3 Saudi Arabia Uveitis Treatment Market by Distribution Channel
    6.4.4.5 South Africa Uveitis Treatment Market
      6.4.4.5.1 South Africa Uveitis Treatment Market by Drug Class
      6.4.4.5.2 South Africa Uveitis Treatment Market by Disease Type
      6.4.4.5.3 South Africa Uveitis Treatment Market by Distribution Channel
    6.4.4.6 Nigeria Uveitis Treatment Market
      6.4.4.6.1 Nigeria Uveitis Treatment Market by Drug Class
      6.4.4.6.2 Nigeria Uveitis Treatment Market by Disease Type
      6.4.4.6.3 Nigeria Uveitis Treatment Market by Distribution Channel
    6.4.4.7 Rest of LAMEA Uveitis Treatment Market
      6.4.4.7.1 Rest of LAMEA Uveitis Treatment Market by Drug Class
      6.4.4.7.2 Rest of LAMEA Uveitis Treatment Market by Disease Type
      6.4.4.7.3 Rest of LAMEA Uveitis Treatment Market by Distribution Channel

CHAPTER 7. COMPANY PROFILES

7.1 AbbVie, Inc.
  7.1.1 Company Overview
  7.1.2 Financial Analysis
  7.1.3 Regional Analysis
  7.1.4 Research & Development Expenses
  7.1.5 Recent strategies and developments:
    7.1.5.1 Approvals:
7.2 Alimera Sciences, Inc.
  7.2.1 Company Overview
  7.2.2 Financial Analysis
  7.2.3 Regional Analysis
  7.2.4 Research & Development Expense
  7.2.1 Recent strategies and developments:
    7.2.1.1 Product Launches and Product Expansions:
7.3 Enzo Biochem, Inc.
  7.3.1 Company Overview
  7.3.2 Financial Analysis
  7.3.3 Segmental and Regional Analysis
  7.3.4 Research & Development Expense
7.4 Amgen, Inc.
  7.4.1 Company Overview
  7.4.2 Financial Analysis
  7.4.3 Research & Development Expense
  7.4.4 Recent strategies and developments:
    7.4.4.1 Product Launches and Product Expansions:
    7.4.4.2 Partnerships, Collaborations, and Agreements:
7.5 Bausch Health Companies, Inc.
  7.5.1 Company Overview
  7.5.2 Financial Analysis
  7.5.3 Segmental and Regional Analysis
  7.5.4 Research & Development Expense
  7.5.5 Recent strategies and developments:
    7.5.5.1 Partnerships, Collaborations, and Agreements:
7.6 Clearside Biomedical, Inc.
  7.6.1 Company Overview
  7.6.2 Financial Analysis
  7.6.3 Research & Development Expense
  7.6.4 Recent strategies and developments:
    7.6.4.1 Partnerships, Collaborations, and Agreements:
7.7 EyePoint Pharmaceuticals, Inc.
  7.7.1 Company Overview
  7.7.2 Financial Analysis
  7.7.3 Regional Analysis
  7.7.4 Research & Development Expense
  7.7.5 Recent strategies and developments:
    7.7.5.1 Product Launches and Product Expansions:
    7.7.5.2 Acquisition and Mergers:
7.8 Santen Pharmaceutical Co., Ltd.
  7.8.1 Company Overview
  7.8.2 Financial Analysis
  7.8.3 Regional Analysis
  7.8.4 Research & Development Expense
  7.8.5 Recent strategies and developments:
    7.8.5.1 Partnerships, Collaborations, and Agreements:
7.9 Topivert Ltd.
  7.9.1 Company Overview
7.1 Novartis AG
  7.10.1 Company Overview
  7.10.2 Financial Analysis
  7.10.3 Segmental and Regional Analysis
  7.10.4 Recent strategies and developments:
    7.10.4.1 Acquisition and Mergers:
    7.10.4.2 Approvals:
  7.10.5 Research & Development Expense

LIST OF TABLES

TABLE 1 GLOBAL UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 2 GLOBAL UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 3 GLOBAL UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 4 GLOBAL UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 5 GLOBAL ANTI-INFLAMMATORY MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 6 GLOBAL ANTI-INFLAMMATORY MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 7 GLOBAL IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 8 GLOBAL IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 9 GLOBAL ANTIMICROBIAL DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 10 GLOBAL ANTIMICROBIAL DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 11 GLOBAL OTHER DRUG CLASS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 12 GLOBAL OTHER DRUG CLASS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 13 GLOBAL UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 14 GLOBAL UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 15 GLOBAL ANTERIOR UVEITIS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 16 GLOBAL ANTERIOR UVEITIS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 17 GLOBAL POSTERIOR UVEITIS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 18 GLOBAL POSTERIOR UVEITIS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 19 GLOBAL INTERMEDIATE UVEITIS MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 20 GLOBAL INTERMEDIATE UVEITIS MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 21 GLOBAL OTHER DISEASES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 22 GLOBAL OTHER DISEASES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 23 GLOBAL UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 24 GLOBAL UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 25 GLOBAL HOSPITAL PHARMACIES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 26 GLOBAL HOSPITAL PHARMACIES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 27 GLOBAL RETAIL PHARMACIES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 28 GLOBAL RETAIL PHARMACIES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 29 GLOBAL ONLINE STORES MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 30 GLOBAL ONLINE STORES MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 31 GLOBAL UVEITIS TREATMENT MARKET BY REGION, 2015 - 2018, USD MILLION
TABLE 32 GLOBAL UVEITIS TREATMENT MARKET BY REGION, 2019 - 2025, USD MILLION
TABLE 33 NORTH AMERICA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 34 NORTH AMERICA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 35 NORTH AMERICA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 36 NORTH AMERICA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 37 NORTH AMERICA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 38 NORTH AMERICA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 39 NORTH AMERICA IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 40 NORTH AMERICA IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 41 NORTH AMERICA ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 42 NORTH AMERICA ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 43 NORTH AMERICA OTHER DRUG CLASS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 44 NORTH AMERICA OTHER DRUG CLASS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 45 NORTH AMERICA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 46 NORTH AMERICA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 47 NORTH AMERICA ANTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 48 NORTH AMERICA ANTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 49 NORTH AMERICA POSTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 50 NORTH AMERICA POSTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 51 NORTH AMERICA INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 52 NORTH AMERICA INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 53 NORTH AMERICA OTHER DISEASE TYPES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 54 NORTH AMERICA OTHER DISEASE TYPES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 55 NORTH AMERICA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 56 NORTH AMERICA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 57 NORTH AMERICA HOSPITAL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 58 NORTH AMERICA HOSPITAL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 59 NORTH AMERICA RETAIL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 60 NORTH AMERICA RETAIL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 61 NORTH AMERICA ONLINE STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 62 NORTH AMERICA ONLINE STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 63 NORTH AMERICA UVEITIS TREATMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 64 NORTH AMERICA UVEITIS TREATMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 65 USA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 66 USA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 67 USA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 68 USA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 69 USA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 70 USA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 71 USA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 72 USA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 73 CANADA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 74 CANADA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 75 CANADA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 76 CANADA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 77 CANADA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 78 CANADA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 79 CANADA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 80 CANADA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 81 MEXICO UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 82 MEXICO UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 83 MEXICO UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 84 MEXICO UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 85 MEXICO UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 86 MEXICO UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 87 MEXICO UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 88 MEXICO UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 89 REST OF NORTH AMERICA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 90 REST OF NORTH AMERICA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 91 REST OF NORTH AMERICA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 92 REST OF NORTH AMERICA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 93 REST OF NORTH AMERICA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 94 REST OF NORTH AMERICA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 95 REST OF NORTH AMERICA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 96 REST OF NORTH AMERICA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 97 EUROPE UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 98 EUROPE UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 99 EUROPE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 100 EUROPE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 101 EUROPE ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 102 EUROPE ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 103 EUROPE IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 104 EUROPE IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 105 EUROPE ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 106 EUROPE ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 107 EUROPE OTHER DRUG CLASS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 108 EUROPE OTHER DRUG CLASS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 109 EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 110 EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 111 EUROPE ANTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 112 EUROPE ANTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 113 EUROPE POSTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 114 EUROPE POSTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 115 EUROPE INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 116 EUROPE INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 117 EUROPE OTHER DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 118 EUROPE OTHER DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 119 EUROPE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 120 EUROPE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 121 EUROPE HOSPITAL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 122 EUROPE HOSPITAL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 123 EUROPE RETAIL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 124 EUROPE RETAIL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 125 EUROPE ONLINE STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 126 EUROPE ONLINE STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 127 EUROPE UVEITIS TREATMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 128 EUROPE UVEITIS TREATMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 129 GERMANY UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 130 GERMANY UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 131 GERMANY UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 132 GERMANY UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 133 GERMANY UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 134 GERMANY UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 135 GERMANY UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 136 GERMANY UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 137 UK UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 138 UK UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 139 UK UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 140 UK UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 141 UK UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 142 UK UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 143 UK UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 144 UK UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 145 FRANCE UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 146 FRANCE UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 147 FRANCE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 148 FRANCE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 149 FRANCE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 150 FRANCE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 151 FRANCE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 152 FRANCE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 153 RUSSIA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 154 RUSSIA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 155 RUSSIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 156 RUSSIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 157 REST OF EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 158 RUSSIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 159 RUSSIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 160 RUSSIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 161 SPAIN UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 162 SPAIN UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 163 SPAIN UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 164 SPAIN UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 165 SPAIN UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 166 SPAIN UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 167 SPAIN UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 168 SPAIN UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 169 ITALY UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 170 ITALY UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 171 ITALY UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 172 ITALY UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 173 REST OF EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 174 ITALY UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 175 ITALY UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 176 ITALY UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 177 REST OF EUROPE UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 178 REST OF EUROPE UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 179 REST OF EUROPE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 180 REST OF EUROPE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 181 REST OF EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 182 REST OF EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 183 REST OF EUROPE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 184 REST OF EUROPE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 185 ASIA PACIFIC UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 186 ASIA PACIFIC UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 187 ASIA PACIFIC UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 188 ASIA PACIFIC UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 189 ASIA PACIFIC ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 190 ASIA PACIFIC ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 191 ASIA PACIFIC IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 192 ASIA PACIFIC IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 193 ASIA PACIFIC ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 194 ASIA PACIFIC ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 195 ASIA PACIFIC OTHER DRUG CLASS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 196 ASIA PACIFIC OTHER DRUG CLASS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 197 ASIA PACIFIC UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 198 ASIA PACIFIC UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 199 ASIA PACIFIC ANTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 200 ASIA PACIFIC ANTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 201 ASIA PACIFIC POSTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 202 ASIA PACIFIC POSTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 203 ASIA PACIFIC INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 204 ASIA PACIFIC INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 205 ASIA PACIFIC OTHER DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 206 ASIA PACIFIC OTHER DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 207 ASIA PACIFIC UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 208 ASIA PACIFIC UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 209 ASIA PACIFIC HOSPITAL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 210 ASIA PACIFIC HOSPITAL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 211 ASIA PACIFIC RETAIL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 212 ASIA PACIFIC RETAIL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 213 ASIA PACIFIC ONLINE STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 214 ASIA PACIFIC ONLINE STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 215 ASIA PACIFIC UVEITIS TREATMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 216 ASIA PACIFIC UVEITIS TREATMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 217 CHINA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 218 CHINA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 219 CHINA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 220 CHINA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 221 CHINA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 222 CHINA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 223 CHINA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 224 CHINA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 225 JAPAN UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 226 JAPAN UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 227 JAPAN UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 228 JAPAN UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 229 JAPAN UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 230 JAPAN UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 231 JAPAN UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 232 JAPAN UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 233 INDIA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 234 INDIA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 235 INDIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 236 INDIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 237 INDIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 238 INDIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 239 INDIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 240 INDIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 241 SOUTH KOREA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 242 SOUTH KOREA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 243 SOUTH KOREA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 244 SOUTH KOREA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 245 SOUTH KOREA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 246 SOUTH KOREA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 247 SOUTH KOREA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 248 SOUTH KOREA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 249 SINGAPORE UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 250 SINGAPORE UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 251 SINGAPORE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 252 SINGAPORE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 253 SINGAPORE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 254 SINGAPORE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 255 SINGAPORE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 256 SINGAPORE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 257 MALAYSIA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 258 MALAYSIA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 259 MALAYSIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 260 MALAYSIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 261 MALAYSIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 262 MALAYSIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 263 MALAYSIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 264 MALAYSIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 265 REST OF ASIA PACIFIC UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 266 REST OF ASIA PACIFIC UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 267 REST OF ASIA PACIFIC UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 268 REST OF ASIA PACIFIC UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 269 REST OF ASIA PACIFIC UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 270 REST OF ASIA PACIFIC UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 271 REST OF ASIA PACIFIC UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 272 REST OF ASIA PACIFIC UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 273 LAMEA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 274 LAMEA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 275 LAMEA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 276 LAMEA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 277 LAMEA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 278 LAMEA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 279 LAMEA IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 280 LAMEA IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 281 LAMEA ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 282 LAMEA ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 283 LAMEA OTHER DRUG CLASS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 284 LAMEA OTHER DRUG CLASS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 285 LAMEA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 286 LAMEA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 287 LAMEA ANTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 288 LAMEA ANTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 289 LAMEA POSTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 290 LAMEA POSTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 291 LAMEA INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 292 LAMEA INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 293 LAMEA OTHER DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 294 LAMEA OTHER DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 295 LAMEA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 296 LAMEA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 297 LAMEA HOSPITAL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 298 LAMEA HOSPITAL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 299 LAMEA RETAIL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 300 LAMEA RETAIL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 301 LAMEA ONLINE STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 302 LAMEA ONLINE STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 303 LAMEA UVEITIS TREATMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 304 LAMEA UVEITIS TREATMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 305 BRAZIL UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 306 BRAZIL UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 307 BRAZIL UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 308 BRAZIL UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 309 BRAZIL UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 310 BRAZIL UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 311 BRAZIL UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 312 BRAZIL UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 313 ARGENTINA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 314 ARGENTINA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 315 ARGENTINA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 316 ARGENTINA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 317 ARGENTINA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 318 ARGENTINA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 319 ARGENTINA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 320 ARGENTINA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 321 UAE UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 322 UAE UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 323 UAE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 324 UAE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 325 UAE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 326 UAE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 327 UAE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 328 UAE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 329 SAUDI ARABIA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 330 SAUDI ARABIA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 331 SAUDI ARABIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 332 SAUDI ARABIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 333 SAUDI ARABIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 334 SAUDI ARABIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 335 SAUDI ARABIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 336 SAUDI ARABIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 337 SOUTH AFRICA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 338 SOUTH AFRICA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 339 SOUTH AFRICA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 340 SOUTH AFRICA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 341 SOUTH AFRICA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 342 SOUTH AFRICA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 343 SOUTH AFRICA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 344 SOUTH AFRICA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 345 NIGERIA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 346 NIGERIA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 347 NIGERIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 348 NIGERIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 349 NIGERIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 350 NIGERIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 351 NIGERIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 352 NIGERIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 353 REST OF LAMEA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
TABLE 354 REST OF LAMEA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
TABLE 355 REST OF LAMEA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
TABLE 356 REST OF LAMEA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
TABLE 357 REST OF LAMEA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
TABLE 358 REST OF LAMEA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
TABLE 359 REST OF LAMEA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 360 REST OF LAMEA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 361 KEY INFORMATION – ABBVIE, INC.
TABLE 362 KEY INFORMATION – ALIMERA SCIENCES, INC.
TABLE 363 KEY INFORMATION – ENZO BIOCHEM, INC.
TABLE 364 KEY INFORMATION – AMGEN, INC.
TABLE 365 KEY INFORMATION – BAUSCH HEALTH COMPANIES, INC.
TABLE 366 KEY INFORMATION – CLEARSIDE BIOMEDICAL, INC.
TABLE 367 KEY INFORMATION – EYEPOINT PHARMACEUTICALS, INC.
TABLE 368 KEY INFORMATION – SANTEN PHARMACEUTICAL CO., LTD.
TABLE 369 KEY INFORMATION – TOPIVERT LTD.
TABLE 370 KEY INFORMATION – NOVARTIS AG

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH


More Publications